An Observational Study of Artificial Intelligence-Assisted Blastocyst Morphokinetic Analysis Using Short-Duration Video and Its Association With Pregnancy Outcomes
Sponsor: Viable Biosciences
Trial Details
| Condition | Infertility Assisted Reproductive Technology, Infertility (IVF Patients) |
| Status | Unknown |
| Participants | 1,000 |
| Est. Completion | 31 Dec 2028 |
| Last Updated | 28 May 2026 |
Primary Outcome
Ongoing Clinical Pregnancy
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Signed Inform Consent * Ages between 18 and 45 years * Patients using own or donated eggs * Patients undergoing assisted reproduction procedures (ICSI with Embryo Transfer, Frozen Embryo Transfers with or without PGT-A receiving a single embryo transfer. * Patients with at least one embryo at the blastocyst stage on day 5, day 6 or day 7 of embryo development. * Patients using a surrogate carrier for the embryo transfer procedure. * Patients with Abnormal Embryos after PGT-A to be discarded. * Patients with Euploid Embryos after PGT-A to be discarded Exclusion Criteria: * Absence of viable embryos at the blastocyst stage. * Any uterine abnormalities that could affect embryo implantation.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service